Since phagocytic NADPH oxidases are predominantly expressed in the innate immune cells [25], total WBC count might serve as a nontraditional potential biomarker for lipid peroxidation and atherosclerosis in the patients with metabolic disorders [25–27]. The gene discussed is FMO5; the disease is metabolic disease.